These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24662139)

  • 1. Incidence of antiretroviral adverse drug reactions in pregnant women in two referral centers for HIV prevention of mother-to-child-transmission care and research in Rio de Janeiro, Brazil.
    Santini-Oliveira M; Friedman RK; Veloso VG; Cunha CB; Pilotto JH; Marins LM; João EC; Torres TS; Grinsztejn B
    Braz J Infect Dis; 2014; 18(4):372-8. PubMed ID: 24662139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of antiretrovirals in HIV-infected pregnant women.
    Zuk DM; Hughes CA; Foisy MM; Robinson JL; Singh AE; Houston S
    Ann Pharmacother; 2009 Jun; 43(6):1028-35. PubMed ID: 19491318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe.
    Dinh TH; Mushavi A; Shiraishi RW; Tippett Barr B; Balachandra S; Shambira G; Nyakura J; Zinyowera S; Tshimanga M; Mugurungi O; Kilmarx PH
    Clin Infect Dis; 2018 Feb; 66(4):576-585. PubMed ID: 29401270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
    Thorne C; Newell ML
    Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of mother-to-child transmission of HIV in pregnancy and among HIV-exposed infants accessing care at a PMTCT clinic in southwest Nigeria.
    Afolabi AY; Bakarey AS; Kolawole OE; Kola OJ
    J Immunoassay Immunochem; 2018; 39(4):403-415. PubMed ID: 30001188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to prevention of mother-to-child transmission of HIV along HIV services cascade through integrated active case management in 15 operational districts in Cambodia.
    Samreth S; Keo V; Tep R; Ke A; Ouk V; Ngauv B; Mam S; Ferradini L; Ly PS; Mean CV; Delvaux T
    J Int AIDS Soc; 2019 Oct; 22(10):e25388. PubMed ID: 31631583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National-level effectiveness of ART to prevent early mother to child transmission of HIV in Namibia.
    Agabu A; Baughman AL; Fischer-Walker C; de Klerk M; Mutenda N; Rusberg F; Diergaardt D; Pentikainen N; Sawadogo S; Agolory S; Dinh TH
    PLoS One; 2020; 15(11):e0233341. PubMed ID: 33170840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse fetal and infant outcomes among HIV-infected women who received either nonnucleoside reverse transcriptase inhibitor-based or protease inhibitor-based antiretroviral therapy for prevention of mother-to-child transmission.
    Masaba R; Borkowf CB; Girde S; Zeh C; Ndivo R; Nyang'au I; Achola K; Thomas TK; Lecher SL
    AIDS; 2018 Jul; 32(12):1625-1632. PubMed ID: 30001243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
    Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
    Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000-10.
    Thorne C; Semenenko I; Malyuta R;
    Addiction; 2012 Jan; 107(1):118-28. PubMed ID: 21819473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 infection and pregnancy in young women in Brazil: socioeconomic and drug resistance profiles in a cross-sectional study.
    Lima YA; Reis MN; Cardoso LP; Stefani MM
    BMJ Open; 2016 Jul; 6(7):e010837. PubMed ID: 27381205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying high or low risk of mother to child transmission of HIV: How Harare City, Zimbabwe is doing?
    Komtenza B; Satyanarayana S; Takarinda KC; Mukungunugwa SH; Mugurungi O; Chonzi P; Sithole N; Bvochora T; Mushavi A
    PLoS One; 2019; 14(3):e0212848. PubMed ID: 30865646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of mother-to-child transmission of HIV in rural Uganda: modelling effectiveness and impact of scaling-up PMTCT services.
    Larsson EC; Ekström AM; Pariyo G; Tomson G; Sarowar M; Baluka R; Galiwango E; Thorson AE
    Glob Health Action; 2015; 8():26308. PubMed ID: 25726836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.